NDC 53002-1755

PIOGLITAZONEHYDROCHLORIDE

Pioglitazonehydrochloride

PIOGLITAZONEHYDROCHLORIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is Pioglitazone Hydrochloride.

Product ID53002-1755_050b9b36-78ef-4b7a-a938-acfa7b12ce09
NDC53002-1755
Product TypeHuman Prescription Drug
Proprietary NamePIOGLITAZONEHYDROCHLORIDE
Generic NamePioglitazonehydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-02-13
Marketing CategoryANDA / ANDA
Application NumberANDA091298
Labeler NameRPK Pharmaceuticals, Inc.
Substance NamePIOGLITAZONE HYDROCHLORIDE
Active Ingredient Strength15 mg/1
Pharm ClassesPeroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 53002-1755-3

30 TABLET in 1 BOTTLE (53002-1755-3)
Marketing Start Date2018-10-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PIOGLITAZONEHYDROCHLORIDE" or generic name "Pioglitazonehydrochloride"

NDCBrand NameGeneric Name
13668-119PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
13668-120PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
13668-140PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
53002-1755PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
53002-1756PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
53002-1757PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
63187-746PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
68071-4822PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
68071-4889PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
70518-1816PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
70518-2059PIOGLITAZONEHYDROCHLORIDEPIOGLITAZONEHYDROCHLORIDE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.